India, March 23 -- Advances in cancer research are improving how doctors diagnose and monitor diseases. One emerging tool is ...

A scan that makes prostate cancer cells “glow” could halve the number of men needing invasive biopsies, research suggests.

Lucida Medical has raised £8.7m to power its ‘same-day’ cancer diagnosis. IW Capital has invested in the Cambridge healthtech ...

An imaging test could safely halve the number of people who need a biopsy for suspected prostate cancer following inconclusive or reassuring results from an MRI scan, new research has found. Findings ...

Lung cancer is the leading cause of death from cancer. It kills more people in the U.S. than breast, prostate, and colon ...

If you’re considering getting a vasectomy, consider that it’s one of the most effective forms of birth control and it’s a ...

Researchers identify gene activity patterns linked to vascular invasion in lung cancer, enabling biopsy-based prediction of aggressive tumors, improving treatment decisions and recurrence risk ...

Younger patients, lack of prostate cancer evidence, future fertility options covered in AU ...

Betsi Cadwaladr University Health Board’s CEO apologised 'for the unacceptable delays' ...

IW Capital has invested in Lucida Medical, a Cambridge and UK healthtech company using AI to help clinicians diagnose prostate cancer from MRI scans faster and more accurately.

Only one in four men takes up the first BowelScreen invitation. The simple test can be carried out at home and only takes a ...

The belief that surgery spreads cancer is a common public misconception. Onco-surgeon Yogeshwar Shukla spoke to Free Press on ...